Franklin Resources
EDIT icon

Franklin Resources’s Editas Medicine EDIT Stock Holding History

Franklin Resources’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,702
Closed -$21.9K – 3196
2025
Q4 		$21.9K Buy
+10,702
New +$30.9K ﹤0.01% 3036
2023
Q1 		– Sell
-19,173
Closed -$170K – 2338
2022
Q4 		$170K Sell
19,173
-626
-3% -$6.87K ﹤0.01% 2034
2022
Q3 		$243K Buy
+19,799
New +$309K ﹤0.01% 1933
2022
Q1 		– Sell
-9,350
Closed -$248K – 2463
2021
Q4 		$248K Buy
9,350
+501
+6% +$17.2K ﹤0.01% 2165
2021
Q3 		$363K Buy
8,849
+4,243
+92% +$232K ﹤0.01% 2012
2021
Q2 		$261K Sell
4,606
-2,114
-31% -$78.1K ﹤0.01% 1764
2021
Q1 		$282K Sell
6,720
-50
-0.7% -$2.85K ﹤0.01% 1721
2020
Q4 		$475K Buy
+6,770
New +$278K ﹤0.01% 1561

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources's EDIT Position: Q1 2026 in Review

Franklin Resources sold out of Editas Medicine (EDIT) in Q1 2026, closing a stake of 10,702 shares — an estimated $21.9K sold.

Franklin Resources first reported a position in EDIT in Q4 2020 and held it in 8 quarters. The position peaked at $475K in Q4 2020. 207 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.

  • Franklin Resources reported no remaining Editas Medicine position as of Q1 2026 after selling out during the quarter.
  • Franklin Resources sold 10,702 Editas Medicine shares in Q1 2026, an estimated $21.9K.
  • Franklin Resources first reported a position in Editas Medicine in Q4 2020 and held it in 8 quarters.
  • Franklin Resources's Editas Medicine position peaked at $475K in Q4 2020.
  • 207 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.

Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.